Your browser doesn't support javascript.
loading
Dual inhibition of EGFR with afatinib and cetuximab in kinase inhibitor-resistant EGFR-mutant lung cancer with and without T790M mutations.
Janjigian, Yelena Y; Smit, Egbert F; Groen, Harry J M; Horn, Leora; Gettinger, Scott; Camidge, D Ross; Riely, Gregory J; Wang, Bushi; Fu, Yali; Chand, Vikram K; Miller, Vincent A; Pao, William.
Afiliação
  • Janjigian YY; Thoracic Oncology and Gastrointestinal Oncology Services, Division of Solid Tumor Oncology, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, New York. Weill Cornell Medical College, New York, New York. janjigiy@mskcc.org.
  • Smit EF; Department of Pulmonary Diseases, Vrije Universiteit VU Medical Center, Amsterdam, the Netherlands.
  • Groen HJ; Department of Pulmonary Diseases, University of Groningen and University Medical Center Groningen, Groningen, the Netherlands.
  • Horn L; Vanderbilt Ingram Cancer Center, Nashville, Tennessee.
  • Gettinger S; Yale University School of Medicine and Yale Cancer Center, New Haven, Connecticut.
  • Camidge DR; University of Colorado Cancer Center, Aurora, Colorado.
  • Riely GJ; Thoracic Oncology and Gastrointestinal Oncology Services, Division of Solid Tumor Oncology, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, New York. Weill Cornell Medical College, New York, New York.
  • Wang B; Boehringer Ingelheim Pharmaceuticals Inc., Ridgefield, Connecticut.
  • Fu Y; Boehringer Ingelheim Pharmaceuticals Inc., Ridgefield, Connecticut.
  • Chand VK; Boehringer Ingelheim Pharmaceuticals Inc., Ridgefield, Connecticut.
  • Miller VA; Thoracic Oncology and Gastrointestinal Oncology Services, Division of Solid Tumor Oncology, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, New York. Weill Cornell Medical College, New York, New York.
  • Pao W; Vanderbilt Ingram Cancer Center, Nashville, Tennessee.
Cancer Discov ; 4(9): 1036-45, 2014 Sep.
Article em En | MEDLINE | ID: mdl-25074459

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Protocolos de Quimioterapia Combinada Antineoplásica / Resistencia a Medicamentos Antineoplásicos / Receptores ErbB / Neoplasias Pulmonares / Mutação Limite: Adult / Aged / Aged80 / Female / Humans / Male / Middle aged Idioma: En Revista: Cancer Discov Ano de publicação: 2014 Tipo de documento: Article

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Protocolos de Quimioterapia Combinada Antineoplásica / Resistencia a Medicamentos Antineoplásicos / Receptores ErbB / Neoplasias Pulmonares / Mutação Limite: Adult / Aged / Aged80 / Female / Humans / Male / Middle aged Idioma: En Revista: Cancer Discov Ano de publicação: 2014 Tipo de documento: Article